Valuation: MEDADVISO

Market Cap 7.65M 5.42M 4.69M 4.41M 4.01M 7.54M 520M 51.71M 20.26M 260M 20.37M 19.92M 866M P/E 2024
385x
P/E 2025 -0.76x
Enterprise Value 14.74M 10.46M 9.03M 8.5M 7.72M 14.52M 1B 99.67M 39.06M 501M 39.26M 38.41M 1.67B EV / Sales 2024
2.23x
EV / Sales 2025 0.92x
Free-Float
61.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 46 07/11/2025
Director of Finance/CFO - 21/07/2025
Chief Tech/Sci/R&D Officer - 30/06/2020
Director TitleAgeSince
Director/Board Member - 10/08/2021
Chairman 67 01/04/2025
Director/Board Member 46 07/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 7.7M
+2.79%+3.80%-12.95%+31.34% 38.72B
+11.88%+11.40%-37.24%+177.58% 13.06B
+1.07%+4.35%-19.60%+71.93% 5.68B
+5.35%+51.40%+49.23% - 3.65B
+2.87%+13.14% - - 2.01B
+0.62%-1.76%+14.55%-38.07% 1.64B
-0.63%-8.19%-39.84% - 982M
+0.96%+1.71%+40.53%+130.58% 932M
-2.22%-4.34%-34.51%-48.32% 830M
Average +2.88%+4.46%-4.98%+54.17% 7.5B
Weighted average by Cap. +4.38%+3.38%-14.14%+65.07%

Financials

2024 2025
Net sales 122M 86.63M 74.82M 70.4M 63.98M 120M 8.3B 826M 324M 4.15B 325M 318M 13.83B 62.99M 44.69M 38.6M 36.32M 33.01M 62.09M 4.28B 426M 167M 2.14B 168M 164M 7.13B
Net income 792K 562K 485K 457K 415K 781K 53.85M 5.36M 2.1M 26.93M 2.11M 2.06M 89.7M -60.21M -42.72M -36.89M -34.71M -31.55M -59.34M -4.09B -407M -160M -2.05B -160M -157M -6.82B
Net Debt -2.97M -2.11M -1.82M -1.71M -1.56M -2.93M -202M -20.09M -7.87M -101M -7.91M -7.74M -336M 7.09M 5.03M 4.35M 4.09M 3.72M 6.99M 482M 47.96M 18.8M 241M 18.89M 18.48M 803M
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-